Aspirin Resistance and Atherothrombotic Disease
- 14 September 2005
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 46 (6) , 986-993
- https://doi.org/10.1016/j.jacc.2004.08.070
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?American Heart Journal, 2004
- Clopidogrel for Coronary StentingCirculation, 2003
- Interleukin-7–Mediated Inflammation in Unstable AnginaCirculation, 2003
- Prevention of Inflammation-Induced Endothelial DysfunctionCirculation, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromes11This study was sponsored by COR Therapeutics Inc., South San Francisco, California; and Schering-Plough Research Institute, Kenilworth, New Jersey.The American Journal of Cardiology, 1999
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Development of aspirin resistance in persons with previous ischemic stroke.Stroke, 1994
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Differential Inhibition by Aspirin of Vascular and Platelet Prostaglandin Synthesis in Atherosclerotic PatientsNew England Journal of Medicine, 1983